Fotemustine active in disseminated malignant melanoma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1434, 2004-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignant Melanoma

By PARKER TIMOTHY ZITELLI JOHN

Dermatologic Surgery, Vol. 22, Iss. 3, 1996-03 ,pp. : 234-240

Elsevier

Access to resources Recommend Favorite

Synthesis and biological evaluation of Fotemustine analogues on human melanoma cell lines

By Winum J.-Y. Bouissiere J.-L. Passagne I. Evrard A. Montero V. Cuq P. Montero J.-L.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 3, 2003-03 ,pp. : 319-324

Elsevier

Access to resources Recommend Favorite

Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC

By Addeo Raffaele Zappavigna Silvia Luce Amalia Facchini Sergio Caraglia Michele

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Mohs Surgery and Malignant Melanoma

By DZUBOW LEONARD M.

Dermatologic Surgery, Vol. 21, Iss. 4, 1995-04 ,pp. : 283-283

Elsevier

Access to resources Recommend Favorite

Malignant Melanoma: Treatment in Evolution

By DZUBOW LEONARD M.

Dermatologic Surgery, Vol. 21, Iss. 11, 1995-11 ,pp. : 924-924

Elsevier

Access to resources Recommend Favorite